The clinical variability between patients carrying the same MEN1 mutation, as well as between members of the same kindred, raises the hypothesis that modifier genes and/or epigenetic tumour-predisposing events might also have a role in the pathogenesis of MEN1 [9]. This evidence concerns the gene MEN1 and neoplasm.